Soledad Garcia de Vinuesa
Overview
Explore the profile of Soledad Garcia de Vinuesa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goicoechea M, de Vinuesa S, Quiroga B, Verde E, Bernis C, Morales E, et al.
Cardiovasc Drugs Ther
. 2018 Jun;
32(3):255-263.
PMID: 29943364
Background: Patients with chronic kidney disease (CKD) are at high risk for developing cardiovascular events. However, limited evidence is available regarding the use of aspirin in CKD patients to decrease...
2.
Goicoechea M, Sanchez-Nino M, Ortiz A, de Vinuesa S, Quiroga B, Bernis C, et al.
Prostaglandins Leukot Essent Fatty Acids
. 2017 Oct;
125:8-13.
PMID: 28987723
Background: Resolution of inflammation is regulated by endogenous lipid mediators, such as lipoxins and their epimers, including 15-epi-lipoxin A4 (15-epi-LXA4). However, there is no information on 15-epi-LXA4 and its in...
3.
Cedeno Mora S, Goicoechea M, Torres E, Verdalles U, Perez de Jose A, Verde E, et al.
Nefrologia
. 2017 May;
37(3):293-300.
PMID: 28495396
Introduction: Scores underestimate the prediction of cardiovascular risk (CVR) as they are not validated in patients with chronic kidney disease (CKD). Two of the most commonly used scores are the...
4.
Verdalles U, Goicoechea M, de Vinuesa S, Quiroga B, Galan I, Verde E, et al.
Nefrologia
. 2016 Jul;
36(5):523-529.
PMID: 27445099
Objective: To estimate the prevalence of RH in patients with different degrees of kidney disease and analyse the characteristics of this group of patients. Methods: A total of 618 patients...
5.
Yuste C, Quiroga B, de Vinuesa S, Goicoechea M, Barraca D, Verdalles U, et al.
Nefrologia
. 2015 Aug;
35(2):150-6.
PMID: 26300508
Background: Vitamin D deficiency and polypharmacy is a common problem over chronic kidney disease (CKD) population. Objectives: To assess the clinical and analytical characteristics of CKD patients with 25-OH-D3 deficiency...
6.
Verdalles U, de Vinuesa S, Goicoechea M, Macias N, Santos A, Perez de Jose A, et al.
Nephrology (Carlton)
. 2015 Mar;
20(8):567-71.
PMID: 25818266
Objective: No consensus has been established as to which is the best fourth-line agent in patients with resistant hypertension (RHT). The aim of the present study was to assess the...
7.
Quiroga B, Galan I, de Vinuesa S, Goicoechea M, Verdalles U, Luno J
Nephrol Dial Transplant
. 2015 Mar;
30(5):801-6.
PMID: 25753805
Background: Increased interarm systolic blood pressure difference (IASBPD) is associated with mortality and cardiovascular (CV) events both in the general population and in patients at high CV risk. The aim...
8.
Goicoechea M, de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, et al.
Am J Kidney Dis
. 2015 Jan;
65(4):543-9.
PMID: 25595565
Background: Asymptomatic hyperuricemia increases renal and cardiovascular (CV) risk. We previously conducted a 2-year, single-blind, randomized, controlled trial of allopurinol treatment that showed improved estimated glomerular filtration rate and reduced...
9.
Vega A, de Vinuesa S, Goicoechea M, Verdalles U, Martinez-Pueyo M, Chacon A, et al.
Int Urol Nephrol
. 2013 Nov;
46(6):1161-7.
PMID: 24265040
Purpose: Estimated glomerular filtration rate (GFR) is a useful tool for the detection of chronic kidney disease (CKD). Several methods have been proposed, but findings can vary in specific groups...
10.
Fernandez-Juarez G, Luno J, Barrio V, de Vinuesa S, Praga M, Goicoechea M, et al.
Clin J Am Soc Nephrol
. 2013 Oct;
8(11):1870-6.
PMID: 24135218
Background And Objectives: Experimental studies show that 25 (OH) vitamin D is a suppressor of renin biosynthesis and that vitamin D deficiency has been associated with CKD progression. Patients with...